Recalls

All US Product Recalls

Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.

How to read this listing

Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.

The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.

Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.

Agency

All agencies FDA (Food)FDA (Drugs)FDA (Devices)USDA FSIS CPSC NHTSA EPA

10651–10675 of 18028

SevereFDA (Drugs)·D-0960-2017·2017-07-19
Teva Recalls Paliperidone Extended-Release Tablets Due to Dissolution Failure
Teva Pharmaceuticals is recalling 360 bottles of Paliperidone Extended-Release Tablets because one tablet failed a routine stability test for drug release.
Product
Paliperidone Extended-Release Tablets, 3 mg, 90 count bottles, Rx only, Manufactured by: Actavis Laboratories FL, Inc., Fort Lauderdale, FL 33314 USA Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054, USA, NDC: 0591-3693-19
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0959-2017·2017-07-19
Bristol-Myers Squibb Recalls Eliquis 5mg Tablets Due to Labeling Error
Bristol-Myers Squibb is recalling 48,180 bottles of Eliquis 5mg tablets because one bottle was found to contain 2.5mg tablets instead.
Product
EliquisTablets 5mg, 60 count bottle, Rx Only, Marketed by: Bristol-Meyers Squibb Company Princeton, NJ 08543 USA and Pfizer Inc. New York, NY 10017 USA, NDC 0003-0894-21
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0973-2017·2017-07-19
Baxter Recalls Sodium Chloride Injection Bags Due to Sterility Concerns
Baxter Healthcare is recalling 295,200 bags of 0.9% Sodium Chloride Injection due to a lack of assurance of sterility and potential for leaking.
Product
SODIUM CHLORIDE — SODIUM CHLORIDE (SODIUM CHLORIDE)
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-0974-2017·2017-07-19
Lupin Recalls Paroxetine Extended-Release Tablets Due to Dissolution Failure
Lupin Pharmaceuticals is recalling Paroxetine Extended-Release Tablets because they failed dissolution testing during stability studies.
Product
PAROXETINE — PAROXETINE (PAROXETINE)
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0952-2017·2017-07-12
Phillips Co. Recalls VenomX Zinc Acetate Skin Protectant Due to GMP Deviations
Phillips Co. is recalling VenomX Zinc Acetate Skin Protectant because FDA inspections found manufacturing practices that question the product's safety and quality.
Product
VenomX, Zinc acetate (.1% by volume), 0.3 fl. oz. (3 mL) bottles, Skin Protectant Phillips Company, Millerton, OK -- NDC 43074-207-01
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0950-2017·2017-07-12
Phillips Co. Recalls StingMed Insect Bites Skin Protectant Due to GMP Deviations
Phillips Co. is recalling StingMed Insect Bites Skin Protectant because FDA inspections found significant manufacturing deviations that raise questions about the product's safety and quality.
Product
StingMed Insect bites Skin Protectant. Zinc acetate (.1% by volume), 0.3 fl. oz. (3 mL) bottle, Phillips Company, Millerton, OK -- NDC 04307-100-11
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0947-2017·2017-07-12
Phillips Tetracycline Ointment Recalled for Manufacturing Quality Concerns
Phillips Co. is recalling Tetracycline-ABC Brand Topical Ointment because FDA inspections found significant manufacturing deviations that raise questions about product safety and quality.
Product
Tetracycline-ABC Brand Topical ointment First Aid Antibiotic, tetracycline (3%), 3 mL in a 5 mL bottle, sold over the counter Phillips Company, Millerton, OK -- NDC 4307410201
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0948-2017·2017-07-12
TetraStem Topical Antibiotic Ointment Recalled for Manufacturing Deviations
Phillips Co. is recalling TetraStem Topical Ointment First Aid Antibiotic because FDA inspections found significant manufacturing deviations that raise questions about product safety and quality.
Product
TetraStem brand Topical Ointment First Aid Antibiotic, tetracycline (3%), 3 mL in a 5 mL bottle, sold over the counter Phillips Company, Millerton, OK -- NDC 04307-301-11
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0949-2017·2017-07-12
Phillips Recalls Diabecline Topical Ointment Due to Manufacturing Deviations
Phillips Co. is recalling Diabecline brand Topical Ointment First Aid Antibiotic because FDA inspections found significant manufacturing deviations that question the product's safety and quality.
Product
Diabecline brand Topical Ointment First Aid Antibiotic, tetracycline (3%), 3 mL in a 5 mL bottle, sold over the counter Phillips Company, Millerton, OK -- NDC 04307-100-11
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0940-2017·2017-07-12
Alvogen Recalls Clindamycin Injection Vials Due to Sterility Concerns
Alvogen, Inc. is recalling 72,575 vials of Clindamycin Injection USP due to a lack of assurance of sterility. The affected lots were distributed nationwide.
Product
Clindamycin Injection USP; 600 mg/4 mL (150 mg/mL). 4 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-463-69
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0946-2017·2017-07-12
Fagron Recalls Succinylcholine Chloride Syringes Due to Sterility Concerns
Fagron Compounding Services is voluntarily recalling 1,056 syringes of Succinylcholine Chloride because the company cannot ensure the product is sterile.
Product
Succinylcholine Chloride, 100 mg per 5mL, 20 mg per mL syringe. IV Use Only. JCB Laboratories, 8710 E 34th St., N. Wichita, KS 67226 UPC 7335968405
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0941-2017·2017-07-12
Alvogen Recalls Clindamycin Injection Vials Due to Sterility Concerns
Alvogen, Inc. is recalling specific lots of Clindamycin Injection USP due to a lack of assurance of sterility. The recall covers 71,825 vials distributed nationwide.
Product
Clindamycin Injection USP; 900 mg/6 mL (150 mg/mL). 6 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-464-69
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0939-2017·2017-07-12
Alvogen Recalls Clindamycin Injection Vials Due to Sterility Concerns
Alvogen, Inc. is recalling 5,100 vials of Clindamycin Injection USP due to a lack of assurance of sterility. The affected product was distributed nationwide.
Product
Clindamycin Injection USP; 300 mg/2 mL (150 mg/mL). 2 mL Single-dose ADD-VANTAGE Vial, Rx Only, Manufactured for Alvogen, Inc., Pine Brook, NJ 07058, NDC 47781-462-69
Category
Drug
Distribution
Distributed nationwide
SevereFDA (Drugs)·D-0951-2017·2017-07-12
Phillips Recalls StaphWash Skin Protectant Due to Manufacturing Deviations
Phillips Co. is recalling StaphWash+Plus+ Skin Protectant because FDA inspections found manufacturing practices that question the product's safety and quality.
Product
StaphWash+Plus+ Skin Protectant, Zinc acetate (.1% by volume), 0.3 fl. oz. (3 mL) bottle, Phillips Company, Millerton, OK -- NDC 43074-101-01
Category
Drug
Distribution
Distributed nationwide
HighFDA (Drugs)·D-0938-2017·2017-07-12
Xttrium Recalls Chlorhexidine Gluconate Oral Rinse Due to CGMP Deviations
Xttrium Laboratories is voluntarily recalling 36,720 bottles of Chlorhexidine Gluconate 0.12% Oral Rinse due to Current Good Manufacturing Practice (CGMP) deviations.
Product
CHLORHEXIDINE GLUCONATE — CHLORHEXIDINE GLUCONATE (CHLORHEXIDINE GLUCONATE)
Category
Drug
Distribution
0 states
ModerateFDA (Drugs)·D-0944-2017·2017-07-12
GSK Recalls Parodontax Toothpaste Due to Possible Metal Presence
GSK Consumer Healthcare is recalling 15,708 tubes of Parodontax Whitening toothpaste due to the possibility of metal in the product.
Product
PARODONTAX — PARODONTAX (STANNOUS FLUORIDE)
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0942-2017·2017-07-12
Lantheus Recalls Fludeoxyglucose F 18 Injection Due to Residual Solvent
Lantheus is recalling 26 doses of Fludeoxyglucose F 18 Injection in Puerto Rico because the product failed impurity specifications for acetonitrile residual solvent.
Product
Fludeoxyglucose F 18 Injection, 20mCi/mL to 200 mCi/mL at EOS, 30 mL Multiple-Dose Vial, Rx Only, Manufactured by: Lantheus MI Radiopharmaceuticals, Inc., San Juan, PR --- NDC 11994-015-01
Category
Drug
Distribution
1 state
ModerateFDA (Drugs)·D-0937-2017·2017-07-12
Methocarbamol USP Recalled for Quality Assurance Deviations
American Pharmaceutical Ingredients LLC is recalling Methocarbamol USP due to lack of quality assurance at the API manufacturer.
Product
Methocarbamol, USP, packaged in a) 100 g container (NDC: 58597-8023-6, b) 500 g container (NDC: 58597-8023-7), c) 1,000 g container (NDC: 58597-8023-8). For Prescription Compounding RX Only. Packed under cGMP conditions by American Pharmaceutical Ingredients, LLC 6650 Highland
Category
Drug
Distribution
Distributed nationwide
ModerateFDA (Drugs)·D-0943-2017·2017-07-12
Sandoz Recalls Amitriptyline Hydrochloride Tablets Due to Cross-Contamination
Sandoz Incorporated is recalling specific lots of Amitriptyline Hydrochloride 25 mg tablets because they were cross-contaminated with Imipramine.
Product
AMITRIPTYLINE HYDROCHLORIDE — AMITRIPTYLINE HYDROCHLORIDE (AMITRIPTYLINE HYDROCHLORIDE)
Category
Drug
Distribution
0 states
ModerateFDA (Drugs)·D-0945-2017·2017-07-12
G & W Clobetasol Propionate Ointment Recalled for Impurity
G & W Laboratories is recalling Clobetasol Propionate Ointment 0.05% due to out-of-specification results for a known impurity.
Product
CLOBETASOL PROPIONATE — CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-0933-2017·2017-07-12
PharMEDium Recalls Ropivacaine Pumps Due to Incorrect Lot and Expiration Dates
PharMEDium Services, LLC is recalling 10 Ropivacaine HCl 0.2% ON-Q pumps nationwide due to incorrect or missing lot and expiration dates.
Product
Ropivacaine HCl 0.2% 750 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 600 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-279-33
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-0935-2017·2017-07-12
PharMEDium Recalls Bupivacaine Pumps Due to Incorrect Labeling
PharMEDium Services is recalling two Bupivacaine HCl ON-Q pumps due to incorrect or missing lot and expiration date labeling.
Product
Bupivacaine HCl 0.25% 270 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 270 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-044-57
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-0930-2017·2017-07-12
PharMEDium Recalls Ropivacaine Pumps Due to Incorrect Labeling
PharMEDium Services is recalling 79 Ropivacaine HCl IV pumps because of incorrect or missing lot and expiration dates.
Product
Ropivacaine HCl 0.2% 400 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 400 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-256-09
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-0934-2017·2017-07-12
PharMEDium Recalls Ropivacaine HCl Injection Due to Labeling Errors
PharMEDium Services, LLC is recalling 21 pumps of Ropivacaine HCl 0.2% injection due to incorrect or missing lot and expiration dates.
Product
Ropivacaine HCl 0.2% 550 mL Total Volume in an AutoFuser Pump in 0.9% Sodium Chloride Injection, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-100-13
Category
Drug
Distribution
Distributed nationwide
LowFDA (Drugs)·D-0932-2017·2017-07-12
PharMEDium Recalls Ropivacaine Pumps Due to Labeling Errors
PharMEDium Services is recalling 147 Ropivacaine HCl IV pumps nationwide because of incorrect or missing lot and expiration dates.
Product
Ropivacaine HCl 0.2% 500 mL Total Volume in an ON-Q Pump in 0.9% Sodium Chloride Injection in 400 mL, Rx Only, Compounded by PharMEDium Services, LLC, Sugar Land, TX 77478, NDC: 61553-258-25
Category
Drug
Distribution
Distributed nationwide

How to read this listing

Filters

10651–10675 of 18028